Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
487.88M | 510.54M | 575.69M | 726.23M | 648.47M | Gross Profit |
181.13M | 171.82M | 210.58M | 294.97M | 305.10M | EBIT |
-92.18M | -113.71M | 122.13M | -19.33M | 36.98M | EBITDA |
-45.17M | -94.13M | 139.62M | 18.94M | -257.85M | Net Income Common Stockholders |
-97.90M | -120.76M | -89.93M | 3.11M | 10.88M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
29.01M | 26.86M | 41.75M | 91.62M | 122.95M | Total Assets |
307.85M | 390.63M | 433.33M | 642.47M | 554.73M | Total Debt |
102.73M | 152.97M | 150.86M | 182.32M | 93.58M | Net Debt |
73.72M | 126.12M | 109.10M | 90.71M | -29.37M | Total Liabilities |
287.64M | 275.02M | 254.44M | 495.93M | 394.48M | Stockholders Equity |
20.20M | 115.42M | 177.96M | 145.77M | 159.91M |
Cash Flow | Free Cash Flow | |||
-25.09M | -69.90M | -66.93M | -87.96M | 42.12M | Operating Cash Flow |
-17.85M | -54.66M | -28.77M | -30.90M | 81.26M | Investing Cash Flow |
-7.53M | -16.06M | -34.50M | -57.06M | -39.14M | Financing Cash Flow |
27.53M | 55.83M | 13.41M | 56.62M | 47.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $6.93B | 11.25 | 2.95% | 3.88% | 2.69% | -24.71% | |
59 Neutral | $61.07M | ― | -6.89% | ― | 5.53% | 15.64% | |
54 Neutral | $140.92M | ― | -3.83% | 4.94% | -11.78% | -13.89% | |
49 Neutral | $118.12M | ― | -186.28% | ― | 8.52% | 98.75% | |
49 Neutral | $50.07M | ― | 8.84% | ― | -16.42% | 88.30% | |
47 Neutral | $86.76M | ― | -199.78% | ― | -10.41% | 53.85% |
On May 2, 2025, Purple Innovation entered into a Second Amendment to its credit agreement, increasing its senior secured term loan facility by $20 million, bringing the total to $100 million. This financial move aims to support Purple’s expansion and investments in innovation and advertising. Additionally, Purple announced a significant expansion of its commercial relationship with Somnigroup International, which will see Purple’s presence in Mattress Firm stores grow from 5,000 to 12,000 mattress slots. This expansion is expected to generate approximately $70 million in incremental net revenue starting in 2026. The strategic supply agreement with Tempur Sherwood, a subsidiary of Somnigroup, will allow Sherwood exclusive rights to assemble certain Purple product lines, while Purple retains its GelFlex Grid technology.
On June 27, 2024, Purple Innovation‘s Board of Directors adopted a stockholder rights agreement, the NOL Rights Plan, to protect $238 million in net operating losses from potential tax limitations due to ownership changes. However, on May 6, 2025, the Board decided to accelerate the plan’s expiration to May 7, 2025, to prevent artificial suppression of share price and remove barriers to new investment, following a strategic review initiated in March 2025.
On March 13, 2025, Purple Innovation announced a strategic review following expressions of interest, forming a special committee to explore options like a sale or merger. The company reported a return to positive adjusted EBITDA and cash flow in Q4 2024, despite a revenue decline, due to cost-saving initiatives and operational improvements. This financial turnaround supports their ‘Path to Premium’ strategy, with plans for continued investment in innovation and advertising.